அறிவியல் ஆராய்ச்சி நிறுவனம் க்கு உயிரியல் பாதுகாப்பு ப்ராப்லம்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Kazakhstan to bottle QazVac COVID-19 vaccine in Almaty rgn
inform.kz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from inform.kz Daily Mail and Mail on Sunday newspapers.
Clinical trials of new Kazakhstani COVID-19 vaccine kick off
inform.kz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from inform.kz Daily Mail and Mail on Sunday newspapers.
First 50,000 doses of QazVak vaccine produced in Kazakhstan
AKIPRESS.COM - Kazakhstan will begin to administer its homegrown coronavirus vaccine to residents next week, primeminister.kz reported.
The first 50,000 doses of the QazVak vaccine were produced by the Scientific Research Institute for Biological Safety Problems in Kazakhstan s southern Jambyl province, Anadolu reports citing the statement. Kazakhstan became one of the top five countries in the world that developed its own vaccine against the pandemic, said Deputy Prime Minister Yerali Tugjanov.
The vaccine was included in the record of the World Health Organization, Tugjanov said, who added that the complete safety of the vaccine has been proven. The biggest advantage of the inactivated vaccine is that it does not cause vaccine-related diseases.
Kazakhstan to apply homegrown COVID vaccine next week
aa.com.tr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aa.com.tr Daily Mail and Mail on Sunday newspapers.
Kazakhstan s Covid-19 vaccine to be bottled in Turkey
500,000 doses of QazVac jabs developed by Kazakhstan against coronavirus to be bottled, packaged in Turkish factory
PHOTO: REUTERS
Bottling and packaging of Kazakhstan s homegrown coronavirus vaccine will be carried out in a factory in Turkey, Kazakh official said on Friday.
Deputy Prime Minister Yerali Tugjanov told reporters the decision on the QazVac vaccine was made because the construction of the production plant has not yet been finalized in Kazakhstan.
He said that controls of the vaccine s 50% compliance with international standards will be completed on April 21. Then, all clinical trials will be evaluated by the Health Ministry and the final report will be published, he said.